查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
外阴阴道念珠菌病药物的全球市场规模、份额和行业趋势分析报告：分销渠道、给药途径（口服、静脉内、局部）、药物类别、区域前景和预测，2022-2028 年版
市场调查报告书
商品编码
1172697

外阴阴道念珠菌病药物的全球市场规模、份额和行业趋势分析报告：分销渠道、给药途径（口服、静脉内、局部）、药物类别、区域前景和预测，2022-2028 年版

Global Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 226 Pages | 订单完成后即时交付

价格

到 2028 年，全球外阴阴道念珠菌病药物市场规模预计将达到 13 亿美元，预测期内復合年增长率为 4.6%。

在这种疾病中，患者意识非常重要。 虽然外阴阴道念珠菌病不会危及生命，但长期和适当的药物治疗是必不可少的，因为当它恶化时会导致可耻的性禁慾。 阴道不适的可能原因包括恶性肿瘤、虐待、外伤、炎症性肠病、性传播疾病和免疫紊乱。 阴道不适的原因包括恶性肿瘤、虐待、外伤、炎症性肠病、性传播疾病和免疫紊乱。

如果您感到阴道疼痛、发红或肿胀，则应诊断为外阴阴道念珠菌病。 外阴阴道念珠菌病需要 4.5 的正常阴道 pH 值。 10% KOH 的湿用可用于破坏隐藏假菌和酵母菌的细胞，提高菌丝和酵母菌的可见度。 重要的是，所有有外阴阴道念珠菌病症状的女性都要用 KOH 製剂进行湿片检测并及时治疗。

COVID-19 影响分析

新型冠状病毒的全球传播对外阴阴道念珠菌病药物市场的增长产生了一定影响。 由于 COVID-19 患者的念珠菌病患病率增加，对外阴阴道念珠菌病药物的需求增加。 这是由于医疗保健相关感染和血液感染的增加，尤其是在住院患者中。 由于这些因素，预计外阴阴道念珠菌病市场将从2020年第一季度开始迅速復苏并继续增长。

市场增长因素

增加研发支出和产品组合扩展

市场推出了多种安全有效的抗真菌药物。 有效的抗真菌剂包括特比□芬、氟康唑和伊曲康唑。 製药行业正在增加研发支出，以扩大其抗感染产品组合。 许多市场参与者专注于为免疫功能低下的患者开发有效的治疗方法，以治疗外阴阴道念珠菌病等真菌感染。

糖尿病发病率上升

全球糖尿病患病率持续上升。 根据世界卫生组织的数据，1980 年约有 1.08 亿人患有糖尿病，但到 2014 年则增加到 4.22 亿。 与高收入国家相比，低收入和中等收入国家的流行率增长更快。 糖尿病是许多严重问题的主要原因之一，包括中风、心力衰竭、失明和肾衰竭。 2014 年，大约 8.5% 的 18 岁以上成年人被诊断患有糖尿病。 随着全球糖尿病患病率的增加，预计外阴阴道念珠菌病病例数也会增加。 这将导致未来几年外阴阴道念珠菌病药物的市场增长。

市场製约因素

服用氟康唑等药物的副作用

氟康唑等医疗药物是用于治疗念珠菌真菌感染（如外阴阴道念珠菌病）的抗真菌药物。 氟康唑可与各种血液稀释剂、抗生素、镇静剂、利尿剂、抗惊厥药和许多其他药物发生相互作用。 此外，药物上列出的各种预防措施适用于患有肝病和其他疾病的人，食用这些疾病可能会导致副作用。

分销渠道前景

外阴阴道念珠菌病药物市场按分销渠道分为医院药店、零售药店和网上药店。 到 2021 年，零售药店部分将见证外阴阴道念珠菌病治疗市场的最高收入份额。 这种疾病的治疗不仅需要短期药物支持，还需要长期药物支持，这推动了零售药店的治疗药物销售。

管理路线展望

外阴阴道念珠菌病药物市场按给药途径分为口服、静脉和外用药物。 到 2021 年，外用药物在外阴阴道念珠菌病市场中占据了很大的收入份额。 这是由于处方药和外用药物（如非处方药）的可用性。 外用OTC包括咪康唑乳膏、塞康唑软膏和克霉唑乳膏，处方製剂包括特康唑乳膏和布康唑乳膏。

药物类别展望

外阴阴道念珠菌病药物市场根据药物类别分为克霉唑、制霉菌素、氟康唑、酮康唑、特比□芬、特康唑等。 2021年，氟康唑板块以最大的收入份额主导了外阴阴道念珠菌病药物市场。 真菌病由于特定原因对公众健康构成重大威胁，这就是为什么世界各地的市场参与者都专注于临床使用氟康唑的研发。

区域展望

按区域分析了北美、欧洲、亚太地区和 LAMEA 的外阴阴道念珠菌病药物市场。 北美地区将在 2021 年以最大的收入份额引领外阴阴道念珠菌病治疗市场。 该地区的市场主导地位主要归功于Johnson & Johnson Services Inc., Pfizer Inc.等市场参与者的存在。 此外，该地区的市场因糖尿病患病率上升而扩大，这可能导致北美国家外阴阴道念珠菌病病例增加。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球外阴阴道念珠菌病药物市场：按分销渠道
    • 全球外阴阴道念珠菌病药物市场：按给药途径分类
    • 全球外阴阴道念珠菌病药物市场：按药物类别
    • 全球外阴阴道念珠菌病药物市场：按地区
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章。全球外阴阴道念珠菌病药物市场：按分销渠道

  • 全球零售药店市场，按地区
  • 全球住院药房市场：按地区
  • 全球在线药店市场：按地区

第 4 章全球外阴阴道念珠菌病药物市场：按给药途径

  • 全球口服药市场：按地区
  • 全球静脉注射市场：按地区
  • 全球外用药物市场：按地区

第 5 章外阴阴道念珠菌病药物的全球市场：按药物类别分类

  • 氟康唑全球市场：按地区
  • 全球克霉唑市场：按地区
  • 全球特康唑市场：按地区
  • 全球特比□芬市场：按地区
  • 全球製霉菌素市场：按地区
  • 全球酮康唑市场：按地区
  • 按地区划分的其他全球市场

第 6 章外阴阴道念珠菌病药物的全球市场：按地区划分的市场

  • 北美
    • 按国家/地区划分的北美外阴阴道念珠菌病药物市场
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲各国外阴阴道念珠菌病药物市场
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 按国家/地区划分的亚太地区外阴阴道念珠菌病药物市场
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉美
    • 按国家/地区划分的 LAMEA 外阴阴道念珠菌病药物市场
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉美地区

第七章公司简介

  • Bayer AG
  • Pfizer, Inc.
  • Bristol Myers Squibb Company
  • Astellas Pharma, Inc.
  • Mycovia Pharmaceuticals, Inc.（NovaQuest Capital Management, LLC）
  • Basilea Pharmaceutica Ltd.
  • Scynexis, Inc.
  • Grupo Ferrer Internacional S.A

The Global Vulvovaginal Candidiasis Treatment Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 4.6% CAGR during the forecast period.

Vulvovaginal Candidiasis is generally caused due to candida Albicans or candida species or yeast. Some of the symptoms of vulvovaginal candidiasis include abnormal vaginal discharge, vaginal soreness, dyspareunia, external dysuria, and pruritis. As per the data provided by the Centers for Disease Control and Prevention, around 75% of women are predicted to have vulvovaginal candidiasis at least one time and 40%-45% of women may have the condition two or more times. The condition is classified as complicated or uncomplicated on the basis of clinical presentation, host factors, microbiology, and response to therapy.

The condition generally rises the need to consider a gynecologist or nurse practitioner. Vulvovaginal Candidiasis can be diagnosed and managed by antifungal medications. Although vulvovaginal candidiasis could be treated in a few days, in cases of complicated situations the treatment could be for a longer period.

Patient awareness is very crucial in this condition. Though vulvovaginal candidiasis is not life-threatening it is essential to have adequate medication over time as it may become worse and lead to withdrawal from sexual activities out of embarrassment. Malignancy, abuse, trauma, inflammatory bowel disease, sexual transmission of infections, and immune disease could be some of the reasons for vaginal discomfort. The patients must undergo a complete and careful physical test, and proper ancillary testing to know about the exact reason for the condition for further treatment.

One should undergo the diagnosis of vulvovaginal candidiasis if the person feels pain, redness, or swelling in the vaginal area. The condition of vulvovaginal candidiasis is linked to normal vaginal pH which is 4.5. Using 10% of KOH in wet preparations helps in improving the visualization of mycelia and yeast via disrupting cellular material which may hide the pseudohyphae or yeast. It is important for all women having symptoms of vulvovaginal candidiasis to undergo an examination of the wet mount with KOH preparation and get treatment on time.

COVID-19 Impact Analysis

The widespread novel coronavirus all over the world has slightly impacted the growth of the vulvovaginal candidiasis treatment market. The demand for drugs for vulvovaginal candidiasis was high due to the rising prevalence of candidiasis among patients who have suffered from COVID-19. This is because of the rise in healthcare-associated infections and bloodstream infections, especially among those who were admitted to hospitals. Owing to all these elements, the vulvovaginal candidiasis market has quickly recovered after the first quarter of 2020 and is further anticipated to continue to grow.

Market Growth Factor

Growing spending on research & development and expansion of product portfolio

The market has been witnessing the introduction of various safe & effective antifungal agents. Some of the effective antifungal agents available in the market are terbinafine, fluconazole, and itraconazole. The pharmaceutical industries are increasing the expenditure on research & development intending to expand their product portfolio for anti-infective drugs. Most of the market players are focusing on the development of effective therapeutic agents for patients with weak immunity systems to cure fungal infections such as vulvovaginal candidiasis.

Rising prevalence of diabetes

The prevalence of diabetes is growing continuously all over the world. According to the data provided by WHO, in 1980, patients with diabetes was around 108 million, which rose to 422 million in 2014. The prevalence has been growing more rapidly in low-income and middle-income nations as compared to high-income nations. Diabetes is one of the reasons for various serious issues such as stroke, heart failure, blindness, kidney failure, and others. In 2014, about 8.5% of adults above the age of 18 were diabetic. As the prevalence of diabetes across the world is growing, the cases of vulvovaginal candidiasis are also predicted to increase. This would result in market growth for the vulvovaginal candidiasis treatment in the upcoming years.

Market Restraining Factor

Side effects of consumption of medicines such as fluconazole

Medicines such as fluconazole are antifungal medications prescribed to cure candida fungal infections such as vulvovaginal candidiasis. The consumption of fluconazole may lead to drug interaction with various blood thinners, antibiotics, sedatives, diuretics, antiseizure, and various other medications. Also, various cautions mentioned on the medicines are applied to individuals having liver disorders or any other diseases which could lead to the side effect of consuming such conditions.

Distribution Channel Outlook

On the basis of distribution channel, the vulvovaginal candidiasis treatment market is divided into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, the retail pharmacy segment witnessed the highest revenue share in the vulvovaginal candidiasis treatment market. The disease treatment takes short as well as long-term support of medications which raises the sale of treatment drugs from retail pharmacies.

Route of Administration Outlook

By route of administration, the vulvovaginal candidiasis treatment market is fragmented into oral, intravenous and topical. The topical segment covered a significant revenue share in the vulvovaginal candidiasis treatment market in 2021. This is attributable to the availability of topical products such as prescription formulations and over-the-counter. Topical OTCs include Miconazole cream, Tioconazole ointment, and Clotrimazole cream and prescription formulations include Terconazole cream and Butoconazole cream.

Drug Class Outlook

Based on drug class, the vulvovaginal candidiasis treatment market is segmented into clotrimazole, nystatin, fluconazole, ketoconazole, terbinafine, terconazole and others. In 2021, the fluconazole segment dominated the vulvovaginal candidiasis treatment market with the maximum revenue share. Fungal diseases pose a crucial threat to public health for certain reasons, due to which the market players across the globe are focused on research & development of clinical use of fluconazole.

Regional Outlook

Region wise, the vulvovaginal candidiasis treatment market analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region led the vulvovaginal candidiasis treatment market by generating the maximum revenue share in 2021. The main factor resulting in the region's dominance in the market is the presence of market players such as Johnson & Johnson Services Inc., Pfizer Inc., and others. Moreover, the regional market is expanding due to the rising prevalence of diabetes in the region, which may lead to increased cases of vulvovaginal candidiasis in the North American nations.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Bristol Myers Squibb Company, Pfizer, Inc., Astellas Pharma, Inc., Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC), Basilea Pharmaceutica Ltd., Scynexis, Inc. and Grupo Ferrer Internacional S.A.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Route of Administration

  • Oral
  • Intravenous
  • Topical

By Drug Class

  • Fluconazole
  • Clotrimazole
  • Terconazole
  • Terbinafine
  • Nystatin
  • Ketoconazole
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bayer AG
  • Bristol Myers Squibb Company
  • Pfizer, Inc.
  • Astellas Pharma, Inc.
  • Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management,LLC)
  • Basilea Pharmaceutica Ltd.
  • Scynexis, Inc.
  • Grupo Ferrer Internacional S.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Vulvovaginal Candidiasis Treatment Market, by Distribution Channel
    • 1.4.2 Global Vulvovaginal Candidiasis Treatment Market, by Route of Administration
    • 1.4.3 Global Vulvovaginal Candidiasis Treatment Market, by Drug Class
    • 1.4.4 Global Vulvovaginal Candidiasis Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel

  • 3.1 Global Retail Pharmacy Market by Region
  • 3.2 Global Hospital Pharmacy Market by Region
  • 3.3 Global Online Pharmacy Market by Region

Chapter 4. Global Vulvovaginal Candidiasis Treatment Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Intravenous Market by Region
  • 4.3 Global Topical Market by Region

Chapter 5. Global Vulvovaginal Candidiasis Treatment Market by Drug Class

  • 5.1 Global Fluconazole Market by Region
  • 5.2 Global Clotrimazole Market by Region
  • 5.3 Global Terconazole Market by Region
  • 5.4 Global Terbinafine Market by Region
  • 5.5 Global Nystatin Market by Region
  • 5.6 Global Ketoconazole Market by Region
  • 5.7 Global Others Market by Region

Chapter 6. Global Vulvovaginal Candidiasis Treatment Market by Region

  • 6.1 North America Vulvovaginal Candidiasis Treatment Market
    • 6.1.1 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.1.1.1 North America Retail Pharmacy Market by Country
      • 6.1.1.2 North America Hospital Pharmacy Market by Country
      • 6.1.1.3 North America Online Pharmacy Market by Country
    • 6.1.2 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Intravenous Market by Country
      • 6.1.2.3 North America Topical Market by Country
    • 6.1.3 North America Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.1.3.1 North America Fluconazole Market by Country
      • 6.1.3.2 North America Clotrimazole Market by Country
      • 6.1.3.3 North America Terconazole Market by Country
      • 6.1.3.4 North America Terbinafine Market by Country
      • 6.1.3.5 North America Nystatin Market by Country
      • 6.1.3.6 North America Ketoconazole Market by Country
      • 6.1.3.7 North America Others Market by Country
    • 6.1.4 North America Vulvovaginal Candidiasis Treatment Market by Country
      • 6.1.4.1 US Vulvovaginal Candidiasis Treatment Market
        • 6.1.4.1.1 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.1.4.1.2 US Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.1.4.1.3 US Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.1.4.2 Canada Vulvovaginal Candidiasis Treatment Market
        • 6.1.4.2.1 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.1.4.2.2 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.1.4.2.3 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.1.4.3 Mexico Vulvovaginal Candidiasis Treatment Market
        • 6.1.4.3.1 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.1.4.3.2 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.1.4.3.3 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.1.4.4 Rest of North America Vulvovaginal Candidiasis Treatment Market
        • 6.1.4.4.1 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.1.4.4.2 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class
  • 6.2 Europe Vulvovaginal Candidiasis Treatment Market
    • 6.2.1 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.2.1.1 Europe Retail Pharmacy Market by Country
      • 6.2.1.2 Europe Hospital Pharmacy Market by Country
      • 6.2.1.3 Europe Online Pharmacy Market by Country
    • 6.2.2 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Intravenous Market by Country
      • 6.2.2.3 Europe Topical Market by Country
    • 6.2.3 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.3.1 Europe Fluconazole Market by Country
      • 6.2.3.2 Europe Clotrimazole Market by Country
      • 6.2.3.3 Europe Terconazole Market by Country
      • 6.2.3.4 Europe Terbinafine Market by Country
      • 6.2.3.5 Europe Nystatin Market by Country
      • 6.2.3.6 Europe Ketoconazole Market by Country
      • 6.2.3.7 Europe Others Market by Country
    • 6.2.4 Europe Vulvovaginal Candidiasis Treatment Market by Country
      • 6.2.4.1 Germany Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.1.1 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.1.2 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.1.3 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.2 UK Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.2.1 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.2.2 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.2.3 UK Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.3 France Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.3.1 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.3.2 France Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.3.3 France Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.4 Russia Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.4.1 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.4.2 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.4.3 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.5 Spain Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.5.1 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.5.2 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.5.3 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.6 Italy Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.6.1 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.6.2 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.6.3 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.2.4.7 Rest of Europe Vulvovaginal Candidiasis Treatment Market
        • 6.2.4.7.1 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.2.4.7.2 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
  • 6.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market
    • 6.3.1 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Retail Pharmacy Market by Country
      • 6.3.1.2 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.1.3 Asia Pacific Online Pharmacy Market by Country
    • 6.3.2 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Intravenous Market by Country
      • 6.3.2.3 Asia Pacific Topical Market by Country
    • 6.3.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.3.1 Asia Pacific Fluconazole Market by Country
      • 6.3.3.2 Asia Pacific Clotrimazole Market by Country
      • 6.3.3.3 Asia Pacific Terconazole Market by Country
      • 6.3.3.4 Asia Pacific Terbinafine Market by Country
      • 6.3.3.5 Asia Pacific Nystatin Market by Country
      • 6.3.3.6 Asia Pacific Ketoconazole Market by Country
      • 6.3.3.7 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country
      • 6.3.4.1 China Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.1.1 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.1.2 China Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.1.3 China Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.2 Japan Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.2.1 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.2.2 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.2.3 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.3 India Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.3.1 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.3.2 India Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.3.3 India Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.4 South Korea Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.4.1 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.4.2 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.4.3 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.5 Singapore Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.5.1 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.5.2 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.5.3 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.6 Malaysia Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.6.1 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.6.2 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.6.3 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.3.4.7 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.3.4.7.2 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
  • 6.4 LAMEA Vulvovaginal Candidiasis Treatment Market
    • 6.4.1 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
      • 6.4.1.1 LAMEA Retail Pharmacy Market by Country
      • 6.4.1.2 LAMEA Hospital Pharmacy Market by Country
      • 6.4.1.3 LAMEA Online Pharmacy Market by Country
    • 6.4.2 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Intravenous Market by Country
      • 6.4.2.3 LAMEA Topical Market by Country
    • 6.4.3 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.3.1 LAMEA Fluconazole Market by Country
      • 6.4.3.2 LAMEA Clotrimazole Market by Country
      • 6.4.3.3 LAMEA Terconazole Market by Country
      • 6.4.3.4 LAMEA Terbinafine Market by Country
      • 6.4.3.5 LAMEA Nystatin Market by Country
      • 6.4.3.6 LAMEA Ketoconazole Market by Country
      • 6.4.3.7 LAMEA Others Market by Country
    • 6.4.4 LAMEA Vulvovaginal Candidiasis Treatment Market by Country
      • 6.4.4.1 Brazil Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.1.1 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.1.2 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.1.3 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.2 Argentina Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.2.1 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.2.2 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.2.3 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.3 UAE Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.3.1 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.3.2 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.3.3 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.4 Saudi Arabia Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.4.1 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.4.2 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.5 South Africa Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.5.1 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.5.2 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.5.3 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.6 Nigeria Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.6.1 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.6.2 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.6.3 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class
      • 6.4.4.7 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
        • 6.4.4.7.2 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class

Chapter 7. Company Profiles

  • 7.1 Bayer AG
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Pfizer, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional & Segmental Analysis
    • 7.2.4 Research & Development Expense
  • 7.3 Bristol Myers Squibb Company
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Astellas Pharma, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management, LLC)
    • 7.5.1 Company Overview
    • 7.5.2 Recent strategies and developments:
      • 7.5.2.1 Trials and Approvals:
  • 7.6 Basilea Pharmaceutica Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Scynexis, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Research & Development Expenses
    • 7.7.4 Recent strategies and developments:
      • 7.7.4.1 Trials and Approvals:
  • 7.8 Grupo Ferrer Internacional S.A.
    • 7.8.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 12 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Intravenous Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Intravenous Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 20 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 21 Global Fluconazole Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Fluconazole Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Clotrimazole Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Clotrimazole Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Terconazole Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Terconazole Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Terbinafine Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Terbinafine Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Nystatin Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Nystatin Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Ketoconazole Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Ketoconazole Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Vulvovaginal Candidiasis Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 36 Global Vulvovaginal Candidiasis Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 37 North America Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 38 North America Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 39 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 40 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 41 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 48 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 49 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Intravenous Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Intravenous Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 56 North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 57 North America Fluconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Fluconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Clotrimazole Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Clotrimazole Market by Country, 2022 - 2028, USD Million
  • TABLE 61 North America Terconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Terconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Terbinafine Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Terbinafine Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Nystatin Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Nystatin Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Ketoconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Ketoconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 72 North America Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 73 US Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 74 US Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 75 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 US Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 78 US Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 79 US Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 80 US Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 81 Canada Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 82 Canada Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 83 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 86 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 87 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 88 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 89 Mexico Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 90 Mexico Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 91 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 92 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 93 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 94 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 95 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 96 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 101 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 102 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 103 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 104 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 105 Europe Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 106 Europe Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 107 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 108 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 109 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 116 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 117 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Intravenous Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Intravenous Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 124 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 125 Europe Fluconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Europe Fluconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Europe Clotrimazole Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Clotrimazole Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Terconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Terconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Terbinafine Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Terbinafine Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Nystatin Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Nystatin Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Europe Ketoconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Europe Ketoconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Europe Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Europe Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Germany Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 142 Germany Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 143 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 146 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 147 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 148 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 149 UK Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 150 UK Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 151 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 154 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 155 UK Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 156 UK Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 157 France Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 158 France Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 159 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 France Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 162 France Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 163 France Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 164 France Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 165 Russia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 166 Russia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 167 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 170 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 171 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 172 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 173 Spain Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 174 Spain Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 175 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 178 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 179 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 180 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 181 Italy Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 182 Italy Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 183 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 186 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 187 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 188 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 189 Rest of Europe Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 190 Rest of Europe Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 191 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 192 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 193 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 194 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 195 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 196 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Intravenous Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Intravenous Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 215 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 216 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 217 Asia Pacific Fluconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 218 Asia Pacific Fluconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Asia Pacific Clotrimazole Market by Country, 2018 - 2021, USD Million
  • TABLE 220 Asia Pacific Clotrimazole Market by Country, 2022 - 2028, USD Million
  • TABLE 221 Asia Pacific Terconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 222 Asia Pacific Terconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 223 Asia Pacific Terbinafine Market by Country, 2018 - 2021, USD Million
  • TABLE 224 Asia Pacific Terbinafine Market by Country, 2022 - 2028, USD Million
  • TABLE 225 Asia Pacific Nystatin Market by Country, 2018 - 2021, USD Million
  • TABLE 226 Asia Pacific Nystatin Market by Country, 2022 - 2028, USD Million
  • TABLE 227 Asia Pacific Ketoconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 228 Asia Pacific Ketoconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 229 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 230 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 231 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 232 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 233 China Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 China Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 236 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 237 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 238 China Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 239 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 240 China Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 241 Japan Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 242 Japan Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 243 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 244 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 245 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 246 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 247 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 248 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 249 India Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 250 India Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 251 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 252 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 253 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 254 India Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 255 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 256 India Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 257 South Korea Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 258 South Korea Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 259 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 260 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 261 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 262 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 263 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 264 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 265 Singapore Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 266 Singapore Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 267 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 268 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 269 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 270 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 271 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 272 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 273 Malaysia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 274 Malaysia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 275 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 276 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 277 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 278 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 279 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 280 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 281 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 282 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 283 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 284 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 285 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 286 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 287 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 288 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 295 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 296 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 297 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 298 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 299 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 300 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 301 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 302 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 303 LAMEA Intravenous Market by Country, 2018 - 2021, USD Million
  • TABLE 304 LAMEA Intravenous Market by Country, 2022 - 2028, USD Million
  • TABLE 305 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 306 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 307 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 308 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 309 LAMEA Fluconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 310 LAMEA Fluconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 311 LAMEA Clotrimazole Market by Country, 2018 - 2021, USD Million
  • TABLE 312 LAMEA Clotrimazole Market by Country, 2022 - 2028, USD Million
  • TABLE 313 LAMEA Terconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 314 LAMEA Terconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 315 LAMEA Terbinafine Market by Country, 2018 - 2021, USD Million
  • TABLE 316 LAMEA Terbinafine Market by Country, 2022 - 2028, USD Million
  • TABLE 317 LAMEA Nystatin Market by Country, 2018 - 2021, USD Million
  • TABLE 318 LAMEA Nystatin Market by Country, 2022 - 2028, USD Million
  • TABLE 319 LAMEA Ketoconazole Market by Country, 2018 - 2021, USD Million
  • TABLE 320 LAMEA Ketoconazole Market by Country, 2022 - 2028, USD Million
  • TABLE 321 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 322 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 323 LAMEA Vulvovaginal Candidiasis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 324 LAMEA Vulvovaginal Candidiasis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 325 Brazil Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 326 Brazil Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 327 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 328 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 329 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 332 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 333 Argentina Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 334 Argentina Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 335 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 336 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 337 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 340 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 341 UAE Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 342 UAE Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 343 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 344 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 345 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 346 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 347 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 348 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 349 Saudi Arabia Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 350 Saudi Arabia Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 351 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 352 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 353 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 354 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 355 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 356 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 357 South Africa Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 358 South Africa Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 359 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 360 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 361 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 362 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 363 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 364 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 365 Nigeria Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 366 Nigeria Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 367 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 368 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 369 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 370 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 371 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 372 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 373 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market, 2018 - 2021, USD Million
  • TABLE 374 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market, 2022 - 2028, USD Million
  • TABLE 375 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 376 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 377 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 378 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 379 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 380 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 381 Key Information - Bayer AG
  • TABLE 382 Key Information - Pfizer, Inc.
  • TABLE 383 Key Information - Bristol Myers Squibb Company
  • TABLE 384 key information - Astellas Pharma, Inc.
  • TABLE 385 Key Information - Mycovia Pharmaceuticals, Inc.
  • TABLE 386 Key Information - Basilea Pharmaceutica Ltd.
  • TABLE 387 Key Information - Scynexis, Inc.
  • TABLE 388 Key Information - Grupo Ferrer Internacional S.A.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Vulvovaginal Candidiasis Treatment Market Share by Distribution Channel, 2021
  • FIG 3 Global Vulvovaginal Candidiasis Treatment Market Share by Distribution Channel, 2028
  • FIG 4 Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Vulvovaginal Candidiasis Treatment Market Share by Route of Administration, 2021
  • FIG 6 Global Vulvovaginal Candidiasis Treatment Market Share by Route of Administration, 2028
  • FIG 7 Global Vulvovaginal Candidiasis Treatment Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 8 Global Vulvovaginal Candidiasis Treatment Market Share by Drug Class, 2021
  • FIG 9 Global Vulvovaginal Candidiasis Treatment Market Share by Drug Class, 2028
  • FIG 10 Global Vulvovaginal Candidiasis Treatment Market by Drug Class, 2018 - 2028, USD Million
  • FIG 11 Global Vulvovaginal Candidiasis Treatment Market Share by Region, 2021
  • FIG 12 Global Vulvovaginal Candidiasis Treatment Market Share by Region, 2028
  • FIG 13 Global Vulvovaginal Candidiasis Treatment Market by Region, 2018 - 2028, USD Million